Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
PRODUCTS
>
Product List
Commercialized Products
INNOVATION
>
Small Molecule Pharmaceuticals
Macromolecule pharmaceuticals
Global Regulatory Registration Support
Commercial cooperation
MEDIA
>
News in NKF
Industry dynamics
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
澳门威斯人58452022秋季校园招聘
2021-09-21
澳门威斯人58452022秋季校园招聘
share
Return
Previous
澳门威斯人5845子公司健进制药注射用卡莫司汀套装首次商业化发运
Next
【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!
Relevant recommendations
2024-05-14
Enoxaparin Sodium Injection of NKF approved in Egypt
2024-05-14
Kindos’ (subsidiary of NKF) Bortezomib for injection getting approved by NMPA, submitted to NMPA and US FDA
2024-04-29
Good news! NKF and Livzon export Cetrorelix Acetate for Injection first time to US
2024-04-23
Nanjing King-Friend attains 6 licensing patents.
2024-04-16
Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection